How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%

Core Viewpoint - Verrica Pharmaceuticals Inc. (VRCA) shows significant upside potential with a mean price target of $15.67, indicating a 97.1% increase from the current trading price of $7.95 [1]. Price Targets - The average price target consists of three estimates ranging from a low of $10.00 to a high of $20.00, with a standard deviation of $5.13, suggesting a variability in analyst predictions [2]. - The lowest estimate indicates a 25.8% increase, while the highest suggests a 151.6% upside [2]. Analyst Sentiment - There is strong agreement among analysts regarding VRCA's ability to exceed previous earnings estimates, which supports the potential for stock price appreciation [4][11]. - The Zacks Consensus Estimate for the current year has increased by 12.9% due to positive revisions in earnings estimates [12]. Zacks Rank - VRCA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13]. Caution on Price Targets - While price targets are a common metric, they should be approached with skepticism as they may not accurately predict stock price movements [3][10]. - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated expectations [8].